Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.08)
# 508
Out of 5,147 analysts
95
Total ratings
34.95%
Success rate
21.67%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVAX Novavax | Maintains: Buy | $11 → $16 | $10.14 | +57.79% | 3 | Feb 27, 2026 | |
| DWTX Dogwood Therapeutics | Reiterates: Buy | $12 | $2.85 | +321.05% | 4 | Feb 20, 2026 | |
| KZIA Kazia Therapeutics | Reiterates: Buy | $18 | $8.45 | +113.02% | 7 | Jan 28, 2026 | |
| PSTV Plus Therapeutics | Maintains: Buy | $2 → $1 | $0.30 | +230.36% | 14 | Jan 23, 2026 | |
| CRVS Corvus Pharmaceuticals | Maintains: Buy | $11 → $27 | $18.26 | +47.86% | 4 | Jan 20, 2026 | |
| ATEC Alphatec Holdings | Reiterates: Buy | $24 | $13.62 | +76.21% | 14 | Jan 12, 2026 | |
| CTSO Cytosorbents | Maintains: Neutral | $1 → $0.75 | $0.75 | -0.33% | 14 | Nov 14, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $1.4 → $19 | $8.27 | +123.70% | 3 | Nov 6, 2025 | |
| AKTX Akari Therapeutics, | Reiterates: Buy | $1.6 | $0.24 | +577.39% | 2 | Sep 9, 2025 | |
| MYO Myomo | Maintains: Buy | $9.5 → $5 | $0.78 | +545.16% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $5.72 | +144.76% | 14 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $54.81 | -27.01% | 10 | Apr 1, 2025 |
Novavax
Feb 27, 2026
Maintains: Buy
Price Target: $11 → $16
Current: $10.14
Upside: +57.79%
Dogwood Therapeutics
Feb 20, 2026
Reiterates: Buy
Price Target: $12
Current: $2.85
Upside: +321.05%
Kazia Therapeutics
Jan 28, 2026
Reiterates: Buy
Price Target: $18
Current: $8.45
Upside: +113.02%
Plus Therapeutics
Jan 23, 2026
Maintains: Buy
Price Target: $2 → $1
Current: $0.30
Upside: +230.36%
Corvus Pharmaceuticals
Jan 20, 2026
Maintains: Buy
Price Target: $11 → $27
Current: $18.26
Upside: +47.86%
Alphatec Holdings
Jan 12, 2026
Reiterates: Buy
Price Target: $24
Current: $13.62
Upside: +76.21%
Cytosorbents
Nov 14, 2025
Maintains: Neutral
Price Target: $1 → $0.75
Current: $0.75
Upside: -0.33%
Senseonics Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $1.4 → $19
Current: $8.27
Upside: +123.70%
Akari Therapeutics,
Sep 9, 2025
Reiterates: Buy
Price Target: $1.6
Current: $0.24
Upside: +577.39%
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5 → $5
Current: $0.78
Upside: +545.16%
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $5.72
Upside: +144.76%
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $54.81
Upside: -27.01%